These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

272 related items for PubMed ID: 9101372

  • 1. The role of testosterone in cyclosporine-induced osteopenia.
    Bowman AR, Sass DA, Dissanayake IR, Ma YF, Liang H, Yuan Z, Jee WS, Epstein S.
    J Bone Miner Res; 1997 Apr; 12(4):607-15. PubMed ID: 9101372
    [Abstract] [Full Text] [Related]

  • 2. Raloxifene analog (LY117018 HCL) ameliorates cyclosporin A-induced osteopenia in oophorectomized rats.
    Bowman AR, Sass DA, Marshall I, Ma YF, Liang H, Jee WS, Epstein S.
    J Bone Miner Res; 1996 Aug; 11(8):1191-8. PubMed ID: 8854256
    [Abstract] [Full Text] [Related]

  • 3. Effect of cyclosporin A on bone mineral metabolism in experimental diabetes mellitus in the rat.
    Epstein S, Takizawa M, Stein B, Katz IA, Joffe II, Romero DF, Liang XG, Li M, Ke HZ, Jee WS.
    J Bone Miner Res; 1994 Apr; 9(4):557-66. PubMed ID: 8030444
    [Abstract] [Full Text] [Related]

  • 4. The bisphosphonate 2-PEBP inhibits cyclosporin A induced high-turnover osteopenia in the rat.
    Movsowitz C, Epstein S, Fallon M, Ismail F, Thomas S.
    J Lab Clin Med; 1990 Jan; 115(1):62-8. PubMed ID: 2299257
    [Abstract] [Full Text] [Related]

  • 5. Influence of age on cyclosporin A-induced alterations in bone mineral metabolism in the rat in vivo.
    Katz I, Li M, Joffe I, Stein B, Jacobs T, Liang XG, Ke HZ, Jee W, Epstein S.
    J Bone Miner Res; 1994 Jan; 9(1):59-67. PubMed ID: 8154310
    [Abstract] [Full Text] [Related]

  • 6. Immunosuppressant use without bone loss--implications for bone loss after transplantation.
    Goodman GR, Dissanayake IR, Sodam BR, Gorodetsky E, Lu J, Ma YF, Jee WS, Epstein S.
    J Bone Miner Res; 2001 Jan; 16(1):72-8. PubMed ID: 11149492
    [Abstract] [Full Text] [Related]

  • 7. Rapamycin: a bone sparing immunosuppressant?
    Romero DF, Buchinsky FJ, Rucinski B, Cvetkovic M, Bryer HP, Liang XG, Ma YF, Jee WS, Epstein S.
    J Bone Miner Res; 1995 May; 10(5):760-8. PubMed ID: 7543725
    [Abstract] [Full Text] [Related]

  • 8. Structural skeletal impairment induced by immunosuppressive therapy in rats: cyclosporine A vs tacrolimus.
    Abdelhadi M, Ericzon BG, Hultenby K, Sjöden G, Reinholt FP, Nordenström J.
    Transpl Int; 2002 Apr; 15(4):180-7. PubMed ID: 11976740
    [Abstract] [Full Text] [Related]

  • 9. Azathioprine alone is bone sparing and does not alter cyclosporin A-induced osteopenia in the rat.
    Bryer HP, Isserow JA, Armstrong EC, Mann GN, Rucinski B, Buchinsky FJ, Romero DF, Epstein S.
    J Bone Miner Res; 1995 Jan; 10(1):132-8. PubMed ID: 7747620
    [Abstract] [Full Text] [Related]

  • 10. Effect of the interaction of parathyroid hormone and cyclosporine a on bone mineral metabolism in the rat.
    Epstein S, Dissanayake IR, Goodman GR, Bowman AR, Zhou H, Ma Y, Jee WS.
    Calcif Tissue Int; 2001 Apr; 68(4):240-7. PubMed ID: 11353952
    [Abstract] [Full Text] [Related]

  • 11. Prostaglandin E2 alleviates cyclosporin A-induced bone loss in the rat.
    Katz IA, Jee WS, Joffe II, Stein B, Takizawa M, Jacobs TW, Setterberg R, Lin BY, Tang LY, Ke HZ.
    J Bone Miner Res; 1992 Oct; 7(10):1191-200. PubMed ID: 1456087
    [Abstract] [Full Text] [Related]

  • 12. Combined treatment with cyclosporin A and cortisone acetate minimizes the adverse bone effects of either agent alone.
    Movsowitz C, Schlosberg M, Epstein S, Ismail F, Fallon M, Thomas S.
    J Orthop Res; 1990 Sep; 8(5):635-41. PubMed ID: 2388102
    [Abstract] [Full Text] [Related]

  • 13. 17 beta-estradiol prevents osteopenia in the oophorectomized rat treated with cyclosporin-A.
    Joffe I, Katz I, Jacobs T, Stein B, Takizawa M, Liu C, Berlin J, Epstein S.
    Endocrinology; 1992 Mar; 130(3):1578-86. PubMed ID: 1537307
    [Abstract] [Full Text] [Related]

  • 14. [Prevention of diltiazem in tacrolimus-induced nephrotoxicity: experiment with rats].
    Chen YH, Liang YX, Chen LQ, Liang JJ, Zhang J, Qiu J, Li WL, Hu JB, Xie KJ, Zhong WD, Chen LZ, Zheng KL.
    Zhonghua Yi Xue Za Zhi; 2007 Aug 28; 87(32):2235-7. PubMed ID: 18001539
    [Abstract] [Full Text] [Related]

  • 15. Interferon-gamma causes loss of bone volume in vivo and fails to ameliorate cyclosporin A-induced osteopenia.
    Mann GN, Jacobs TW, Buchinsky FJ, Armstrong EC, Li M, Ke HZ, Ma YF, Jee WS, Epstein S.
    Endocrinology; 1994 Sep 28; 135(3):1077-83. PubMed ID: 8070349
    [Abstract] [Full Text] [Related]

  • 16. The endothelin receptor antagonist, L-754,142 does not prevent cyclosporine A-induced osteopenia in rats.
    Sodam BR, Awumey EM, Sampson WH, Epstein S.
    Calcif Tissue Int; 2001 Feb 28; 68(2):117-21. PubMed ID: 11310347
    [Abstract] [Full Text] [Related]

  • 17. Combined flurbiprofen and cyclosporin-A does not attenuate bone loss and exaggerates renal impairment.
    Sass DA, Rucinski B, Bryer HP, Mann GN, Yuan Z, Ma Y, Jee WS, Epstein S.
    Bone; 1996 Oct 28; 19(4):381-6. PubMed ID: 8894144
    [Abstract] [Full Text] [Related]

  • 18. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program .
    Natl Toxicol Program Tech Rep Ser; 1993 Sep 28; 422():1-340. PubMed ID: 12616289
    [Abstract] [Full Text] [Related]

  • 19. Skeletal effects of low-dose cyclosporin A in aged male rats: lack of relationship to serum testosterone levels.
    Erben RG, Stangassinger M, Gärtner R.
    J Bone Miner Res; 1998 Jan 28; 13(1):79-87. PubMed ID: 9443793
    [Abstract] [Full Text] [Related]

  • 20. Effects of cerivastatin on vascularized allogenic bone transplantation in rats treated with cyclosporine A.
    Ohno T, Shigetomi M, Ihara K, Ikeda K, Tsubone T, Matsunaga T, Sugiyama T, Kawai S.
    Calcif Tissue Int; 2003 Jan 28; 72(1):50-6. PubMed ID: 12384812
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.